Breaking News
Black Friday SALE: Up to 54% off InvestingPro! Register here
Investing Pro 0
Ad-Free Version. Upgrade your experience. Save up to 40% More details

Looking Ahead of Wall Street: RXII, TTNP, MU

By TipRanks (Carly Forster)Stock MarketsMar 30, 2015 09:38AM ET,-ttnp,-mu-246734
Looking Ahead of Wall Street: RXII, TTNP, MU
By TipRanks (Carly Forster)   |  Mar 30, 2015 09:38AM ET
Saved. See Saved Items.
This article has already been saved in your Saved Items

It’s an exciting week ahead for the biotech and technology sectors as three big players are scheduled to announce their quarterly financial results. What should investors watch out for this week?

Rxi Pharmac (NASDAQ:RXII):

RXI Pharmaceuticals is slated to announce its fourth quarter and year end 2014 financial results on Monday, March 30th after market close. The company is expected to post a loss of -$0.14 a share, up from a loss of -$0.36 a share the same quarter a year prior.

RXI Pharmaceuticals is a biotechnology company who focuses on developing therapies related to dermatology and ophthalmology. On March 23rd, the company reported several significant advancements within its dermatological programs at the annual meeting of the American Academy of Dermatology in San Francisco, California. Most notably, the company addressed the study of the clinical effect of RXI-109 versus a placebo in reducing recurring keloids following a Keloidectomy. The study showed that during a four week trial, keloids treated with RXI-109 reduced at a faster rate than keloids treated with a placebo. The company will move forward with the study using stronger doses of RXI-109.

The company also revealed it has reached a partnership with Dr. James Krueger of The Rockefeller University and Dr. Maria Hordinsky of the University of Minnesota for the studies of the effects of Samcyprone on the changes in gene expression profiles influenced by diphencyprone and in the treatment of alopecia areata, respectively.
Despite this, RXI Pharmaceuticals shares dropped 5.15% at the end of trading on March 27th.

Currently there is not enough data available to determine the analyst consensus for RXII.

Titan Pharma Inc (OBB:TTNP):

Titan Pharmaceuticals is set to announce its fourth quarter and full year 2014 earnings results on Wednesday, April 1st before the opening bell. The company is expected to post a loss of -$0.01 a share, down from $0.00 the same quarter last year.

Titan Pharmaceuticals is a biomedical pharmaceutical company most known for its flagship drug, Probuphine, used to treat opioid addiction. Probuphine has proved to be effective in two clinical studies and one safety study. Titan is in the process of completing one more clinical study before receiving FDA approval, which is expected to be completed by mid-2015.

Currently opioid deterring medications, such as Suboxone, require daily patient compliance. This decreases the patient’s chance of successfully completing the regime. Probuphine is a six-month implant that eliminates the possibility of patients terminating treatment on their own, making it attractive to investors.

On average, the top analyst consensus for Titan Pharmaceuticals on TipRanks is Strong Buy.

Micron Technology (NASDAQ:MU):

Micron is scheduled to announce its second quarter 2015 financial results on Thursday, April 2nd after market close. The company is expected to post earnings of $0.79 a share, down from $0.85 a share the same quarter a year prior.

Micron is best known for producing semiconductor devices, including DRAM, SDRAM, flash memory chips, and SSDs. On March 17th, the technology company announced a new line of “ultra” memory products intended to enable next-generation cars.

Just last week, Micron also announced with Intel (NASDAQ:INTC) that 3D NAND technology, the world’s highest-density flash memory, is now available. 3D NAND technology is now expected to make a significant impact on Micron’s financials by simultaneously raking in more revenue while saving on costs.

On average, the top analyst consensus for Micron Technology on TipRanks is Moderate Buy.

Looking Ahead of Wall Street: RXII, TTNP, MU

Related Articles

Trading Point
Can Anything Stop The Stock Market? By Trading Point  - Nov 26, 2021

Stock markets have gone on an absolute rampage this year. The problem is that the factors that initially fueled this rally - heavy government spending and endless central bank...

Anna Coulling
Is This A Fake Move In U.S. Markets? By Anna Coulling - Nov 26, 2021 2

As US markets open in the midst of the Thanksgiving holiday season, it’s been a traumatic start to the end of the week, with all three indices trading sharply lower, with the Dow...

Looking Ahead of Wall Street: RXII, TTNP, MU

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at’s discretion.

Write your thoughts here
Are you sure you want to delete this chart?
Post also to:
Replace the attached chart with a new chart ?
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Are you sure you want to delete this chart?
Replace the attached chart with a new chart ?
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
Continue with Google
Sign up with Email